Objective:This research aims to investaigate the effect of cetuximab and dendritic cells(DCs)to kill the head and neck squamous cell(HNSCC),in order to provide a new way for the patients of HNSCC.Method:DCs were induced from peripheral blood monocytes by rhIL-4,rhGM-CSF and TNF-αin vitro,7days later,detecting the surface marks of DCs for example CD83,CD86,and then using MTT and flow cytometry detecting the effect T lymphocytes induced by DCs combining cetuximab to kill HNSCC;EGFR and pEGFR in each group wer...
【基金】
辽宁省计划项目课题(No:2012225019)
【更新日期】
2014-08-19
【分类号】
R739.91
【正文快照】
头颈部鳞状细胞癌(head and neck spuamouscell carcinoma,HNSCC)约占头颈部恶性肿瘤的95%〔1-2〕。据报道,HNSCC已排在全世界最常见的恶性肿瘤第6位,给全世界各国人民的健康带来了严重的威胁〔3〕。虽然在临床中肿瘤的诊断与治疗水平有了很大提高,但是由于头颈部血供与淋巴组?